Canada markets closed

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6220-0.0130 (-2.05%)
At close: 12:16PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.6350
Open0.6335
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6190 - 0.6335
52 Week Range0.2130 - 0.8820
Volume3,135
Avg. Volume962
Market Cap20.007M
Beta (5Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
  • Canntab Announces Closing of Convertible Debenture Private Placement
    Newsfile

    Canntab Announces Closing of Convertible Debenture Private Placement

    Toronto, Ontario--(Newsfile Corp. - December 31, 2020) - Canntab Therapeutics Limited. (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) ("Canntab" or the "Company"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the closing of a non-brokered private placement (the "Offering") of secured convertible debentures of the Company ("Convertible Debentures"), pursuant to which the Company issued Convertible Debentures for gross proceeds of $1,575,000 (the "Convertible Debentures"). The ...

  • CNW Group

    COVID-19 Pandemic - The government presents its daily update

    QUÉBEC CITY, Nov. 28, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 1,480 new cases, bringing the total number of people infected to 139,643.

  • Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus
    Newsfile

    Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

    Toronto, Ontario--(Newsfile Corp. - November 16, 2020) -  Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that Canntab and Exactus, Inc. have mutually agreed to terminate the supply and distribution agreements previously announced on November 20, 2019, after determining that the regulatory requirements could not be completed on a timely basis.During a time ...